Pollen.com adds new features for allergy season

Share this article:
Pollen.com adds new features for allergy season
Pollen.com adds new features for allergy season
Pollen.com, an allergy site for consumers, is getting revamped with new features for the upcoming allergy season.

New features include a customizable dashboard – MyPollen – that offers allergy information to registered users based on their geographic location, and a Pollen Diary to keep track of symptoms. The dashboard provides local pollen forecasts, top pollen areas with pictures and links, current weather information and historic pollen count information.

For advertisers, the MyPollen dashboard will serve up pharmaceutical and other allergy-related ads that can be geographically targeted to consumers, according to Glenn Connery, associate director of SDI's application development group. Ads are served against geographic-specific content on the four-day forecast function on Pollen.com as well, said Connery.

Pollen.com also has an Allergy Alert iPhone app for accessing four-day forecasts or one-day alerts. Owners of an iPhone can enter a zip code manually, or use an auto-detect function to locate the device geographically. Once a location is determined, alerts and forecasts about pollen, cold and cough, asthma and humidity index levels are delivered direct to the mobile device, according to Connery.

The website, which garners unique visitor traffic in the neighborhood of three million per month during peak allergy season, is maintained in-house. Online marketing firm WebPageFX was enlisted during Pollen.com's redesign to “maximize our exposure to search engines and increase our site's organic traffic,” said Connery.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...